Vacancies on the advisory committees for the Center for Drug Evaluation and Research remain a problem for FDA, despite overall improvement in vacancy rates among all agency advisory panels.
The advisory committee vacancy rate hit an all-time low of 14% at the end of fiscal year 2013, down from 40% in FY 2008, the agency said in its quarterly...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?